| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: group of inventions refers to a pharmaceutical composition for phosphate adsorption in a body and/or from biological fluids when administered orally or externally, and to a biologically active food additive. The pharmaceutical composition and the biologically active food additive contains a physical mixture or a combination of powders, granules, crystals or chips of calcium, magnesium or iron salts in a certain mole relation of Ca 2+ , Mg 2+ and Fe 3+ . The concentration of Ca +2 is 80 mg - 2,400 mg; the concentration of Mg + is 49 mg - 729 mg and the concentration of Fe +3 is 112 mg - 1,676 mg in a daily dose. n EFFECT: invention provides effective binding of phosphate in a wide range of pH levels causing no overdosage of the consumed phosphate-binding compounds and enabling avoiding the related side effects. n 20 cl, 10 dwg, 5 tbl, 16 ex |